Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,687 | -2,922 | -865 | -4,307 | -19,039 |
| Depreciation Amortization | 8,118 | 8,499 | 3,845 | 4,365 | 4,659 |
| Income taxes - deferred | -398 | -2,861 | -1,584 | -279 | 15,116 |
| Accounts receivable | 468 | -2,792 | 196 | 566 | -1,340 |
| Accounts payable and accrued liabilities | -2,048 | N/A | -918 | -2,413 | 2,577 |
| Other Working Capital | 42 | -1,675 | -3,811 | -41 | -2,719 |
| Other Operating Activity | 6,550 | 4,635 | 4,194 | 7,492 | 1,451 |
| Operating Cash Flow | $8,045 | $2,884 | $1,057 | $5,383 | $705 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,216 | -986 | -878 | -1,445 | -2,954 |
| Net Acquisitions | 1,002 | -52,794 | N/A | 1,417 | -4,545 |
| Other Investing Activity | -15 | -16 | -39 | -34 | -18 |
| Investing Cash Flow | $-229 | $-53,796 | $-917 | $-62 | $-7,517 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,300 | 70,700 | 2,750 | 4,000 | 5,800 |
| Debt Repayment | -11,703 | -20,198 | -4,702 | -9,050 | -8,350 |
| Common Stock Issued | -221 | 4,557 | 160 | 182 | 2,042 |
| Other Financing Activity | 0 | -2,006 | 0 | 0 | -32 |
| Financing Cash Flow | $-7,624 | $53,053 | $-1,792 | $-4,868 | $-540 |
| Exchange Rate Effect | -30 | 299 | 1,789 | -1,601 | -38 |
| Beginning Cash Position | 8,173 | 5,733 | 5,596 | 6,744 | 14,134 |
| End Cash Position | 8,335 | 8,173 | 5,733 | 5,596 | 6,744 |
| Net Cash Flow | $162 | $2,440 | $137 | $-1,148 | $-7,390 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,045 | 2,884 | 1,057 | 5,383 | 705 |
| Capital Expenditure | -1,216 | -986 | -890 | -1,445 | -2,960 |
| Free Cash Flow | 6,829 | 1,898 | 167 | 3,938 | -2,255 |